Valuation Grand Pharmaceutical Group Limited OTC Markets

Stocks

Market Closed - OTC Markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

08-26	Grand Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-10	Grand Pharma's Cancer Diagnostic Candidate Gets FDA Fast Track Status; Shares Jump 5%	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	22,930	16,225	14,394	16,809	27,489	16,809	-	-
Change	-	-29.24%	-11.29%	16.78%	63.54%	-38.85%	-	-
Enterprise Value (EV)	22,930	16,225	14,394	16,809	27,489	16,809	16,809	16,809
Change	-	-29.24%	-11.29%	16.78%	63.54%	-38.85%	0%	0%
P/E	-	-	7.63x	6.81x	22.2x	9.32x	8.53x	7.58x
PBR	1.71x	1.14x	0.94x	1.02x	1.62x	0.94x	0.89x	0.83x
PEG	-	-	-	0.2x	-0.4x	0.2x	0.92x	0.6x
Capitalization / Revenue	2.67x	1.7x	1.37x	1.44x	2.24x	1.3x	1.19x	1.07x
EV / Revenue	0x	0x	0x	0x	0x	1.3x	1.19x	1.07x
EV / EBITDA	0x	-	-	0x	0x	5.69x	5.35x	4.63x
EV / EBIT	0x	0x	0x	0x	0x	7.36x	6.77x	5.89x
EV / FCF	0x	0x	0x	0x	0x	9.26x	8.37x	7.76x
FCF Yield	6.69%	7.5%	13.5%	7.99%	3.36%	10.8%	11.9%	12.9%
Dividend per Share ²	-	0.14	0.26	0.26	0.169	0.21	0.23	0.32
Rate of return	-	3.04%	6.36%	5.42%	2.15%	4.38%	4.79%	6.67%
EPS ²	-	-	0.536	0.7049	0.3544	0.515	0.5625	0.6333
Distribution rate	-	-	48.5%	36.9%	47.7%	40.8%	40.9%	50.5%
Net sales ¹	8,598	9,562	10,530	11,645	12,283	12,944	14,102	15,717
EBITDA ¹	3,218	-	-	3,536	2,238	2,952	3,141	3,630
EBIT ¹	2,879	2,654	2,549	3,033	1,656	2,283	2,482	2,852
Net income ¹	-	-	1,880	2,468	1,241	1,826	1,991	2,244
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	6.460	4.600	4.090	4.800	7.850	4.800	4.800	4.800
Nbr of stocks (in thousands)	3,549,571	3,527,141	3,519,271	3,501,810	3,501,810	3,501,810	-	-
Announcement Date	3/17/22	3/22/23	3/19/24	3/12/25	3/26/26	-	-	-

¹HKD in Million²HKD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.45x	11.78x	23.93x	0.61%	1,019B
JOHNSON & JOHNSON	28.48x	6.32x	17.7x	2.09%	617B
ABBVIE INC.	33.26x	7.78x	16.08x	2.64%	464B
MERCK & CO., INC.	104.98x	5.87x	24.89x	2.36%	356B
ROCHE HOLDING AG	18.81x	4.58x	11.36x	2.9%	333B
NOVARTIS AG	19.83x	5.17x	12.78x	3.09%	267B
ASTRAZENECA PLC	20.02x	4.17x	11.86x	2.13%	244B
AMGEN INC.	25.46x	6.66x	11.86x	2.5%	218B
GILEAD SCIENCES, INC.	-43.78x	6.39x	24.97x	2.27%	179B
Average	26.61x	6.52x	17.27x	2.29%	410.8B
Weighted average by Cap.	31.80x	7.61x	18.61x	1.96%